Kenneth Reay Code - Nov 14, 2025 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Science Officer, Director
Signature
/s/ John R. Browning, attorney-in-fact
Stock symbol
BLGO
Transactions as of
Nov 14, 2025
Transactions value $
$50,201
Form type
4
Date filed
11/17/2025, 08:12 PM
Previous filing
Jul 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CODE KENNETH REAY Chief Science Officer, Director 14921 CHESTNUT ST., WESTMINSTER /s/ John R. Browning, attorney-in-fact 2025-11-17 0001370684

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLGO Common Stock Award $50.2K +314K +1.23% $0.16 25.8M Nov 14, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer.
F2 Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
F3 Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.